Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,633,411 papers from all fields of science
Search
Sign In
Create Free Account
TEI 9063
Known as:
TEI-9063
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Partial Agonism of Taprostene at Prostanoid IP Receptors in Vascular Preparations from Guinea-Pig, Rat, and Mouse
K. Chan
,
Robert L. Jones
Journal of Cardiovascular Pharmacology
2004
Corpus ID: 25998693
This study investigates whether incomplete relaxation of vascular smooth muscle preparations induced by the prostacyclin analogue…
Expand
1997
1997
Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
R. L. Jones
,
Y. Qian
,
+5 authors
J. K. Ho
Journal of Cardiovascular Pharmacology
1997
Corpus ID: 25946564
The specific prostacyclin (IP) receptor agonist cicaprost relaxed human pulmonary artery preparations precontracted with…
Expand
1991
1991
Inhibition by prostacyclin and carbacyclins of endothelin-induced DNA synthesis in cultured vascular smooth muscle cells.
T. Nakaki
,
M. Ohta
,
R. Kato
Prostaglandins, Leukotrienes and Essential Fatty…
1991
Corpus ID: 25341145
1991
1991
TEI-9063, a stable and highly specific prostacyclin analogue for the prostacyclin receptor in mastocytoma P-815 cells.
M. Negishi
,
H. Hashimoto
,
K. Yatsunami
,
S. Kurozumi
,
A. Ichikawa
Prostaglandins
1991
Corpus ID: 24244962
1991
1991
Inhibition of endothelin-1-induced DNA synthesis by prostacyclin and its stable analogues in vascular smooth muscle cells.
T. Nakaki
,
M. Ohta
,
R. Kato
Journal of Cardiovascular Pharmacology
1991
Corpus ID: 21797323
The effects of prostacyclin and its stable analogues on endothelin-induced DNA synthesis were investigated in cultured vascular…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required